The level of properdin was increased in PCOS-nonGH, PCOS-GH, and PCOS-SGH compared to controls (p < 0.001), but levels did not differ between the PCOS-nonGH and PCOS-GH and PCOS-SGH groups (Supplementary Figure S1). This evidence concerns the gene CFP and polycystic ovary syndrome.